-
1
-
-
0034053718
-
Neuroblastoma: Current drug therapy recommendations as part of the total treatment approach
-
Berthold F, Hero B. Neuroblastoma: current drug therapy recommendations as part of the total treatment approach. Drugs 2000;59: 1261-77. (Pubitemid 30410144)
-
(2000)
Drugs
, vol.59
, Issue.6
, pp. 1261-1277
-
-
Berthold, F.1
Hero, B.2
-
2
-
-
70249150426
-
Congenital neuroblastoma with liver metastasis presenting with Hashimoto Pritzker disease
-
Jacob ES, Varghese RG, Toi PC, Bhaskaran R, Rai R. Congenital neuroblastoma with liver metastasis presenting with Hashimoto Pritzker disease. Ind J Pathol Microbiol 2009;52:374-6.
-
(2009)
Ind J Pathol Microbiol
, vol.52
, pp. 374-376
-
-
Jacob, E.S.1
Varghese, R.G.2
Toi, P.C.3
Bhaskaran, R.4
Rai, R.5
-
3
-
-
0033509949
-
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
-
DOI 10.1097/00043426-199905000-00005
-
DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999;21:181-9. (Pubitemid 30306028)
-
(1999)
Journal of Pediatric Hematology/Oncology
, vol.21
, Issue.3
, pp. 181-189
-
-
DuBois, S.G.1
Kalika, Y.2
Lukens, J.N.3
Brodeur, G.M.4
Seeger, R.C.5
Atkinson, J.B.6
Haase, G.M.7
Black, C.T.8
Perez, C.9
Shimada, H.10
Gerbing, R.11
Stram, D.O.12
Matthay, K.K.13
-
4
-
-
77749307470
-
Incidence of pediatric Horner syndrome and the risk of neuroblastoma: A population-based study
-
Smith SJ, Diehl N, Leavitt JA, Mohney BG. Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study. Arch Ophthalmol 2010;128:324-29.
-
(2010)
Arch Ophthalmol
, vol.128
, pp. 324-329
-
-
Smith, S.J.1
Diehl, N.2
Leavitt, J.A.3
Mohney, B.G.4
-
5
-
-
4944248113
-
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
-
DOI 10.1158/0008-5472.CAN-04-0695
-
Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res 2004;64:6883-91. (Pubitemid 39330995)
-
(2004)
Cancer Research
, vol.64
, Issue.19
, pp. 6883-6891
-
-
Wei, J.S.1
Greer, B.T.2
Westermann, F.3
Steinberg, S.M.4
Son, C.-G.5
Chen, Q.-R.6
Whiteford, C.C.7
Bilke, S.8
Krasnoselsky, A.L.9
Cenacchi, N.10
Catchpoole, D.11
Berthold, F.12
Schwab, M.13
Khan, J.14
-
6
-
-
77951938957
-
Regulation of redox signaling by selenoproteins
-
Hawkes WC, Alkan Z. Regulation of redox signaling by selenoproteins. Biol Trace Elem. Res 2010;134:235-51.
-
(2010)
Biol Trace Elem. Res
, vol.134
, pp. 235-251
-
-
Hawkes, W.C.1
Alkan, Z.2
-
7
-
-
33746799839
-
Phase I trial of oral fenretinide in children with high-risk solid tumors: A report from the Children's Oncology Group (CCG 09709)
-
Children's Oncology Group (CCG 09709)
-
Children's Oncology Group (CCG 09709),Khan J, Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, et al. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). J Clin Oncol 2006;24:3423-30.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3423-3430
-
-
Khan, J.1
Villablanca, J.G.2
Krailo, M.D.3
Ames, M.M.4
Reid, J.M.5
Reaman, G.H.6
-
8
-
-
0038176443
-
Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma
-
Garaventa A, Luksch R, Lo Piccolo MS, Cavadini E, Montaldo PG, Pizzitola MR, et al. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 2003;9:2032-39. (Pubitemid 36687622)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.6
, pp. 2032-2039
-
-
Garaventa, A.1
Luksch, R.2
Lo, P.M.S.3
Cavadini, E.4
Montaldo, P.G.5
Pizzitola, M.R.6
Boni, L.7
Ponzoni, M.8
Decensi, A.9
De Bernardi, B.10
Bellani, F.F.11
Formelli, F.12
-
9
-
-
71449103247
-
High-risk neuroblastoma: A therapy in evolution
-
Fong A, Park JR. High-risk neuroblastoma: A therapy in evolution. Pediatr Hematol Oncol 2009;26:539-48.
-
(2009)
Pediatr Hematol Oncol
, vol.26
, pp. 539-548
-
-
Fong, A.1
Park, J.R.2
-
10
-
-
77950489450
-
Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment-Niigata Tumor Board Study
-
Kubota M, Okuyama N, Hirayama Y, Asami K, Ogawa A, Watanabe A. Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment-Niigata Tumor Board Study. J Pediatr Surg 2010;45:673-77.
-
(2010)
J Pediatr Surg
, vol.45
, pp. 673-677
-
-
Kubota, M.1
Okuyama, N.2
Hirayama, Y.3
Asami, K.4
Ogawa, A.5
Watanabe, A.6
-
11
-
-
77953024995
-
Neuroblastoma: Therapeutic strategies for a clinical enigma
-
Modak S, Cheung NK. Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev 2010;36:307-17.
-
(2010)
Cancer Treat Rev
, vol.36
, pp. 307-317
-
-
Modak, S.1
Cheung, N.K.2
-
12
-
-
0025828899
-
Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation
-
Seeger RC, Reynolds CP. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 1991;38:393-424.
-
(1991)
Pediatr Clin North Am
, vol.38
, pp. 393-424
-
-
Seeger, R.C.1
Reynolds, C.P.2
-
13
-
-
0030812075
-
Concomitant p53 mutation and MYCN amplification if neuroblastoma
-
DOI 10.1002/(SICI)1096-911X(199709)29:3<206::AID-MPO7>3.0.CO;2-H
-
Manhani R, Cristofani LM, Odone Filho V, Bendit I. Concomitant p53 mutation and MYCN amplification in neuroblastoma. Med Pediatr Oncol 1997;29:206-7. (Pubitemid 27291142)
-
(1997)
Medical and Pediatric Oncology
, vol.29
, Issue.3
, pp. 206-207
-
-
Manhani, R.1
Cristofani, L.M.2
Filho, V.O.3
Bendit, I.4
-
14
-
-
0035881581
-
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines
-
Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, et al. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 2001;61:6185-93. (Pubitemid 32768583)
-
(2001)
Cancer Research
, vol.61
, Issue.16
, pp. 6185-6193
-
-
Keshelava, N.1
Zuo, J.J.2
Chen, P.3
Waidyaratne, S.N.4
Luna, M.C.5
Gomer, C.J.6
Triche, T.J.7
Reynolds, C.P.8
-
15
-
-
0032493125
-
Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
-
Houldsworth J, Xiao H, Murty VV, Chen W, Ray B, Reuter VE, et al. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 1998;16:2345-9. (Pubitemid 28226881)
-
(1998)
Oncogene
, vol.16
, Issue.18
, pp. 2345-2349
-
-
Houldsworth, J.1
Xiao, H.2
Murty, V.V.V.S.3
Chen, W.4
Ray, B.5
Reuter, V.E.6
Bosl, G.J.7
Chaganti, R.S.K.8
-
18
-
-
0033646912
-
P53 mutations and loss of P53 function confer multidrug resistance in neuroblastoma
-
Keshelava N, Zuo JJ, Waidyaratne NS, Triche TJ, Reynolds CP. P53 mutations and loss of P53 function confer multidrug resistance in neuroblastoma. Med Pediatr Oncol 2000;35:563-8.
-
(2000)
Med Pediatr Oncol
, vol.35
, pp. 563-568
-
-
Keshelava, N.1
Zuo, J.J.2
Waidyaratne, N.S.3
Triche, T.J.4
Reynolds, C.P.5
-
19
-
-
0042023468
-
Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): A novel link between G-protein and tyrosine kinase signaling and drug resistance
-
DOI 10.1002/ijc.11260
-
Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC. Transport of glutathione-conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J cancer 2003;106:635-46. (Pubitemid 36993386)
-
(2003)
International Journal of Cancer
, vol.106
, Issue.5
, pp. 635-646
-
-
Awasthi, S.1
Singhal, S.S.2
Sharma, R.3
Zimniak, P.4
Awasthi, Y.C.5
-
20
-
-
77951299314
-
RLIP76: A versatile transporter and an emerging target for cancer therapy
-
Vatsyayan R, Lelsani P, Awasthi S, Singhal SS. RLIP76: a versatile transporter and an emerging target for cancer therapy. Biochem Pharmacol 2010;79:1699-705.
-
(2010)
Biochem Pharmacol
, vol.79
, pp. 1699-1705
-
-
Vatsyayan, R.1
Lelsani, P.2
Awasthi, S.3
Singhal, S.S.4
-
21
-
-
55849138371
-
Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction
-
Chesler L, Goldenberg DD, Collins R, Grimmer M, Kim GE, Tihan T, et al. Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction. Neoplasia 2008;10: 1268-74.
-
(2008)
Neoplasia
, vol.10
, pp. 1268-1274
-
-
Chesler, L.1
Goldenberg, D.D.2
Collins, R.3
Grimmer, M.4
Kim, G.E.5
Tihan, T.6
-
22
-
-
3242690522
-
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation
-
Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 2004;24:6728-41.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 6728-6741
-
-
Erster, S.1
Mihara, M.2
Kim, R.H.3
Petrenko, O.4
Moll, U.M.5
-
23
-
-
0032401845
-
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
-
Keshelava N, Seeger RC, Groshen S, Reynolds CP. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res 1998;58:5396-405. (Pubitemid 28551122)
-
(1998)
Cancer Research
, vol.58
, Issue.23
, pp. 5396-5405
-
-
Keshelava, N.1
Seeger, R.C.2
Groshen, S.3
Reynolds, C.P.4
-
24
-
-
0034622633
-
Novel Function of Human RLIP76: ATP-Dependent Transport of Glutathione Conjugates and Doxorubicin
-
DOI 10.1021/bi992964c
-
Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S, et al. Novel function of human RLIP76: ATP-dependent transport of glutathione- conjugates and doxorubicin. Biochemistry 2000;39:9327-34. (Pubitemid 30626323)
-
(2000)
Biochemistry
, vol.39
, Issue.31
, pp. 9327-9334
-
-
Awasthi, S.1
Cheng, J.2
Singhal, S.S.3
Saini, M.K.4
Pandya, U.5
Pikula, S.6
Bandorowicz-Pikula, J.7
Singh, S.V.8
Zimniak, P.9
Awasthi, Y.C.10
-
25
-
-
27244461486
-
RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes
-
DOI 10.1006/abbi.2001.2395
-
Sharma R, Singhal SS, Cheng J, Yang Y, Sharma A, Zimniak P, et al. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes. Arch Biochem Biophys 2001;391:171-9. (Pubitemid 32662258)
-
(2001)
Archives of Biochemistry and Biophysics
, vol.391
, Issue.2
, pp. 171-179
-
-
Sharma, R.1
Singhal, S.S.2
Cheng, J.3
Yang, Y.4
Sharma, A.5
Zimniak, P.6
Awasthi, S.7
Awasthi, Y.C.8
-
26
-
-
0030922149
-
Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation
-
DOI 10.1074/jbc.272.18.12229
-
Aumais JP, Lee HS, Lin R, White JH. Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation. J Biol Chem 1997;272:12229-35. (Pubitemid 27202809)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.18
, pp. 12229-12235
-
-
Aumais, J.P.1
Lee, H.S.2
Lin, R.3
White, J.H.4
-
27
-
-
0032515938
-
ATP-dependent human erythrocyte glutathione-conjugate transporter. II. Functional reconstitution of transport activity
-
Awasthi S, Singhal SS, Pikula S, Piper JT, Srivastava SK, Torman RT, et al. ATP-dependent human erythrocyte glutathione-conjugate transporter. II. Functional reconstitution of transport activity. Biochemistry 1998;37:5239-48.
-
(1998)
Biochemistry
, vol.37
, pp. 5239-5248
-
-
Awasthi, S.1
Singhal, S.S.2
Pikula, S.3
Piper, J.T.4
Srivastava, S.K.5
Torman, R.T.6
-
28
-
-
11144331446
-
Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses
-
DOI 10.1021/bi0482811
-
Yadav S, Singhal SS, Singhal J, Wickramarachchi D, Knutson E, Albrecht TB, et al. Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses. Biochemistry 2004;43: 16243-53. (Pubitemid 40041037)
-
(2004)
Biochemistry
, vol.43
, Issue.51
, pp. 16243-16253
-
-
Yadav, S.1
Singhal, S.S.2
Singhal, J.3
Wickramarachchi, D.4
Knutson, E.5
Albrecht, T.B.6
Awasthi, Y.C.7
Awasthi, S.8
-
29
-
-
24044498698
-
The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer
-
DOI 10.1016/j.febslet.2005.07.032, PII S001457930500880X
-
Singhal SS, Yadav S, Singhal J, Drake K, Awasthi YC, Awasthi S. The role of PKCa and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer. FEBS Lett 2005;579:4635-41. (Pubitemid 41218639)
-
(2005)
FEBS Letters
, vol.579
, Issue.21
, pp. 4635-4641
-
-
Singhal, S.S.1
Yadav, S.2
Singhal, J.3
Drake, K.4
Awasthi, Y.C.5
Awasthi, S.6
-
30
-
-
28644448262
-
Savior and slayer: The two faces of p53
-
DOI 10.1038/nm1205-1278
-
Bensaad K, Vousden KH. Savior and slayer: the two faces of p53. Nat Med 2005;11:1278-9. (Pubitemid 41752901)
-
(2005)
Nature Medicine
, vol.11
, Issue.12
, pp. 1278-1279
-
-
Bensaad, K.1
Vousden, K.H.2
-
31
-
-
33846849632
-
Role of 4-hydroxynonenal and its metabolites in signaling
-
DOI 10.1179/135100007X162211
-
Dwivedi S, Sharma A, Patrick B, Sharma R, Awasthi YC. Role of 4-hydroxynonenal and its metabolites in signaling. Redox Rep 2007; 12:4-10. (Pubitemid 46210346)
-
(2007)
Redox Report
, vol.12
, Issue.1-2
, pp. 4-10
-
-
Dwivedi, S.1
Sharma, A.2
Patrick, B.3
Sharma, R.4
Awasthi, Y.C.5
-
32
-
-
33645130457
-
Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen
-
Lee YS, Wan J, Kim BJ, Bae MA, Song BJ. Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. J Pharmacol Exp Ther 2006;317:202-8.
-
(2006)
J Pharmacol Exp Ther
, vol.317
, pp. 202-208
-
-
Lee, Y.S.1
Wan, J.2
Kim, B.J.3
Bae, M.A.4
Song, B.J.5
-
33
-
-
33750505407
-
CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation
-
DOI 10.1016/j.yexmp.2006.07.007, PII S0014480006000864
-
Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, et al. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (mallory body-like) formation. Exp Mol Pathol 2006;81:191-201. (Pubitemid 44665867)
-
(2006)
Experimental and Molecular Pathology
, vol.81
, Issue.3
, pp. 191-201
-
-
Bardag-Gorce, F.1
French, B.A.2
Nan, L.3
Song, H.4
Nguyen, S.K.5
Yong, H.6
Dede, J.7
French, S.W.8
-
34
-
-
0026029555
-
Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid
-
Tonini GP, Parodi MT, Di Martino D, Varesio L. Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett 1991;280:221-4.
-
(1991)
FEBS Lett
, vol.280
, pp. 221-224
-
-
Tonini, G.P.1
Parodi, M.T.2
Di Martino, D.3
Varesio, L.4
-
35
-
-
27244460626
-
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
-
DOI 10.1200/JCO.2005.05.571
-
London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the children's oncology group. J Clin Oncol 2005;23:6459-65. (Pubitemid 46190236)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.27
, pp. 6459-6465
-
-
London, W.B.1
Castleberry, R.P.2
Matthay, K.K.3
Look, A.T.4
Seeger, R.C.5
Shimada, H.6
Thorner, P.7
Brodeur, G.8
Maris, J.M.9
Reynolds, C.P.10
Cohn, S.L.11
-
36
-
-
0030919377
-
Neuroblastoma in adults and adolescents: An indolent course with poor survival
-
DOI 10.1002/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0. CO;2-V
-
Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997;79:2028-35. (Pubitemid 27200389)
-
(1997)
Cancer
, vol.79
, Issue.10
, pp. 2028-2035
-
-
Franks, L.M.1
Bollen, A.2
Seeger, R.C.3
Stram, D.O.4
Matthay, K.K.5
-
37
-
-
0033509949
-
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
-
DOI 10.1097/00043426-199905000-00005
-
DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999;21:181-9. (Pubitemid 30306028)
-
(1999)
Journal of Pediatric Hematology/Oncology
, vol.21
, Issue.3
, pp. 181-189
-
-
DuBois, S.G.1
Kalika, Y.2
Lukens, J.N.3
Brodeur, G.M.4
Seeger, R.C.5
Atkinson, J.B.6
Haase, G.M.7
Black, C.T.8
Perez, C.9
Shimada, H.10
Gerbing, R.11
Stram, D.O.12
Matthay, K.K.13
-
38
-
-
0030999641
-
Targeted expression of MYCN causes neuroblastoma in transgenic mice
-
DOI 10.1093/emboj/16.11.2985
-
Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997;16:2985-95. (Pubitemid 27234938)
-
(1997)
EMBO Journal
, vol.16
, Issue.11
, pp. 2985-2995
-
-
Weiss, W.A.1
Aldape, K.2
Mohapatra, G.3
Feuerstein, B.G.4
Bishop, J.M.5
-
39
-
-
0033580238
-
MycN sensitizes neuroblastoma cells for drug-induced apoptosis
-
Fulda S, Lutz W, Schwab M, Debatin KM. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 1999;18: 1479-86. (Pubitemid 29103635)
-
(1999)
Oncogene
, vol.18
, Issue.7
, pp. 1479-1486
-
-
Fulda, S.1
Lutz, W.2
Schwab, M.3
Debatin, K.-M.4
-
40
-
-
0031727309
-
Prognostic significance of MYCN oncogene expression in childhood neuroblastoma
-
Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 1998;16:3286-94. (Pubitemid 28481623)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.10
, pp. 3286-3294
-
-
Bordow, S.B.1
Norris, M.D.2
Haber, P.S.3
Marshall, G.M.4
Haber, M.5
-
41
-
-
33644552409
-
Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse
-
Carr J, Bell E, Pearson AD, Kees UR, Beris H, Lunec J, et al. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse. Cancer Res 2006;66: 2138-45.
-
(2006)
Cancer Res
, vol.66
, pp. 2138-2145
-
-
Carr, J.1
Bell, E.2
Pearson, A.D.3
Kees, U.R.4
Beris, H.5
Lunec, J.6
-
42
-
-
14144250455
-
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
-
DOI 10.1073/pnas.0405495102
-
Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, et al. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci 2005;102:731-6. (Pubitemid 40282734)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.3
, pp. 731-736
-
-
Slack, A.1
Chen, Z.2
Tonelli, R.3
Pule, M.4
Hunt, L.5
Pession, A.6
Shohet, J.M.7
-
43
-
-
0035798564
-
Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress
-
Cheng JZ, Sharma R, Yang Y, Singhal SS, Sharma A, Saini MK, et al. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J Biol Chem 2001;276:41213-23.
-
(2001)
J Biol Chem
, vol.276
, pp. 41213-41223
-
-
Cheng, J.Z.1
Sharma, R.2
Yang, Y.3
Singhal, S.S.4
Sharma, A.5
Saini, M.K.6
-
44
-
-
0042232500
-
RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate Epsin during the switch off of endocytosis in mitosis
-
DOI 10.1074/jbc.M302191200
-
Rosse C, L'Hoste S, Offner N, Picard A, Camonis J. RLIP, an effector of the ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem 2003;278:30597-604. (Pubitemid 36994564)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.33
, pp. 30597-30604
-
-
Rosse, C.1
L'Hoste, S.2
Offner, N.3
Picard, A.4
Camonis, J.5
-
45
-
-
0029089074
-
Bridging ral GTPase to rho pathways. RLIP76, a ral effector with CDC42/Rac GTPase-activating protein activity
-
Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, et al. Bridging ral GTPase to rho pathways. RLIP76, a ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 1995;270:22473-7.
-
(1995)
J Biol Chem
, vol.270
, pp. 22473-22477
-
-
Jullien-Flores, V.1
Dorseuil, O.2
Romero, F.3
Letourneur, F.4
Saragosti, S.5
Berger, R.6
-
46
-
-
69849088365
-
Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis
-
Singhal SS, Yadav S, Vatsyayan R, Chaudhary P, Borvak J, Singhal J, et al. Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis. Cancer Lett 2009;283:152-8.
-
(2009)
Cancer Lett
, vol.283
, pp. 152-158
-
-
Singhal, S.S.1
Yadav, S.2
Vatsyayan, R.3
Chaudhary, P.4
Borvak, J.5
Singhal, J.6
-
47
-
-
50349092152
-
Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1
-
Singhal SS, Yadav S, Drake K, Singhal J, Awasthi S. Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.J Biol Chem 2008;283:19714-29.
-
(2008)
J Biol Chem
, vol.283
, pp. 19714-19729
-
-
Singhal, S.S.1
Yadav, S.2
Drake, K.3
Singhal, J.4
Awasthi, S.5
-
48
-
-
33644530955
-
Regression of melanoma in a murine model by RLIP76 depletion
-
Singhal SS, Awasthi YC, Awasthi S. Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 2006;66:2354-60.
-
(2006)
Cancer Res
, vol.66
, pp. 2354-2360
-
-
Singhal, S.S.1
Awasthi, Y.C.2
Awasthi, S.3
-
49
-
-
34249322665
-
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (ral-binding protein 1)
-
DOI 10.1158/0008-5472.CAN-06-4124
-
Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, et al. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (ral-binding protein 1). Cancer Res 2007;67:4382-9. (Pubitemid 46815087)
-
(2007)
Cancer Research
, vol.67
, Issue.9
, pp. 4382-4389
-
-
Singhal, S.S.1
Singhal, J.2
Yadav, S.3
Dwivedi, S.4
Boor, P.J.5
Awasthi, Y.C.6
Awasthi, S.7
-
50
-
-
66249146631
-
RLIP76: A target for kidney cancer therapy
-
Singhal SS, Singhal J, Yadav S, Sahu M, Awasthi YC, Awasthi S. RLIP76: a target for kidney cancer therapy. Cancer Res 2009;69: 4244-51.
-
(2009)
Cancer Res
, vol.69
, pp. 4244-4251
-
-
Singhal, S.S.1
Singhal, J.2
Yadav, S.3
Sahu, M.4
Awasthi, Y.C.5
Awasthi, S.6
|